[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Contempo Updates
March 16, 2005

The Prospect of Silencing Disease Using RNA Interference

Author Affiliations
 

Contempo Updates Section Editor: Sarah Ringold, MD, Fishbein Fellow.

 

Author Affiliations: CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Mass.

JAMA. 2005;293(11):1367-1373. doi:10.1001/jama.293.11.1367
Abstract

The discovery of RNA interference (RNAi), an endogenous cellular gene-silencing mechanism, has already provided a powerful tool for basic science researchers to study gene function. The subsequent finding that RNAi also operates in mammalian cells has generated excitement regarding potential therapeutic applications. In this article we discuss the basic mechanism of RNAi and the therapeutic opportunities and obstacles for harnessing RNAi for therapy of human disease.

×